🧪 Clinical Trial Protocol – Glycurex

Project Type: Mock Double-Blind Randomized Controlled Trial

Therapeutic Area: Type 2 Diabetes Mellitus

Role: Lead Protocol Developer

Duration: June 2025

Platform: Self-Driven + GPT + PubMed Research

Objective

To design a humanized, protocol-driven RCT evaluating the safety and efficacy of Glycurex in T2DM patients using global ICH-GCP standards.

Key Sections

• Study Title
• Investigational Product (Glycurex)
• Study Rationale
• Methodology & Randomization
• Eligibility Criteria
• Safety Monitoring Plan
• Informed Consent Ethics
• References

📎 C:\Users\saksh\OneDrive\Desktop\Publication Glycurex Clinical Trial Protocol.docx